Shukra Pharmaceuticals Ltd — Important, 06-07-2026: Company Update

Shukra Pharmaceuticals announced that its Registrar and Transfer Agent confirmed the proper processing of all physical shares submitted for dematerialization. This means shares received for conversion into electronic form were verified, confirmed, and shareholder records updated with depositories efficiently and within timelines. This routine operational update is vital for maintaining accurate share registration and facilitating smooth trading, assuring investors their securities are handled correctly.